信函:肠神经病变在多动性谱系障碍/多动性埃勒-丹洛斯综合征中不存在吗?

IF 6.6 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Caitlin Green, Anne Maitland, Steven A. Kautz, Russell Norris, Sunil Patel, Amol Sharma
{"title":"信函:肠神经病变在多动性谱系障碍/多动性埃勒-丹洛斯综合征中不存在吗?","authors":"Caitlin Green,&nbsp;Anne Maitland,&nbsp;Steven A. Kautz,&nbsp;Russell Norris,&nbsp;Sunil Patel,&nbsp;Amol Sharma","doi":"10.1111/apt.70142","DOIUrl":null,"url":null,"abstract":"<p>We commend Sweerts et al. for their largest-to-date investigation using antroduodenal manometry (ADM) in 50 patients with hypermobility spectrum disorders (HSD) and hypermobile Ehler-Danlos Syndrome (hEDS) compared to 189 non-HSD/hEDS patients [<span>1</span>]. ADM, a labour-intensive and technically challenging procedure, comes the closest to the gold standard of histopathological evaluation of full-thickness tissue specimens for diagnosing enteric myopathy or neuropathy. Key findings of the study were similar rates of antroduodenal dysmotility and delayed gastric emptying, but less enteric dysmotility in HSD/hEDS patients. As discussed, malnutrition was highly prevalent with 76% of HSD/hEDS patients receiving enteral (62%) or parenteral (13%) support. In contrast, the non-HSD/hEDS comparator group had nearly double the proportion of patients not receiving enteral or parenteral nutrition, suggesting differences in meal tolerability. The ADM protocol employed in this study only allowed a ‘one shot’ assessment of enteric function via a single meal. While logistical and technical challenges exist, 24-h recordings present more opportunities to detect enteric motility between meals, in response to multiple meals, in response to a non-meal stimulus through promotility agents, and diurnal variation [<span>2</span>]. The conclusion of a lower prevalence of enteric dysmotility in the HSD/hEDS cohort based on a single meal challenge in patients with poor meal tolerability during ADM may be premature.</p><p>Delayed gastric emptying was present in 85% of the HSD/hEDS cohort. While validated symptom scores for gastroparesis and/or functional dyspepsia were not captured, the corresponding predominant symptom was a cardinal gastroparesis symptom in most patients (nausea/vomiting &gt; 50% and abdominal pain and excessive fullness ~25% of HSD/hEDS group), projected to meet diagnostic criteria for gastroparesis. In gastroparesis overall (i.e., not limited to HSD/hEDS), constipation remains understudied and poorly understood from a pathophysiological standpoint. Fifty-eight percent of patients with gastroparesis have moderate to very severe constipation, and the severity of constipation symptoms correlates with the severity of gastroparesis symptoms [<span>3</span>]. Based on our clinical observations and the lack of use of a prospective stool diary in this study, constipation was probably underreported by HSD/hEDS participants. Underlying rectal evacuation disorders are key drivers of pathophysiology in severe constipation and are present in 60%–75% of patients with HSD/hEDS undergoing anorectal manometry [<span>4, 5</span>].</p><p>While the prevalence of enteric dysmotility or neuropathy in HSD/hEDS remains unclear, more than half of HSD/hEDS patients have associated postural orthostatic tachycardia syndrome and dysautonomia [<span>6</span>]. Transauricular vagal nerve stimulation targeting dysautonomia is promising for functional dyspepsia, also highly prevalent in HSD/hEDS, and improves autonomic function with the ability to monitor and adjust settings remotely [<span>7, 8</span>]. Furthermore, radiologically occult tethered cord syndrome can co-occur with cranio-cervical or cervical instability in patients with hEDS, and surgical management may help in select cases [<span>9</span>]. Neuromodulation of thoracic spinal nerves has shown promise in a proof-of-concept study of patients with diabetic gastroparesis, and is undergoing a sham-controlled randomised clinical trial. It may be beneficial in select cases associated with dysautonomia [<span>10</span>].</p><p>In conclusion, patients with HSD/hEDS suffer from substantial gastrointestinal symptoms and dysfunction. Further studies into understanding the underlying pathophysiology to drive mechanistic treatments are urgently needed.</p><p><b>Caitlin Green:</b> writing – original draft, writing – review and editing. <b>Anne Maitland:</b> writing – review and editing. <b>Steven A. Kautz:</b> writing – review and editing. <b>Russell Norris:</b> writing – review and editing. <b>Sunil Patel:</b> writing – review and editing. <b>Amol Sharma:</b> writing – original draft, writing – review and editing, supervision, conceptualization, visualization, project administration.</p><p>The authors declare no conflicts of interest.</p><p>This article is linked to Sweerts et al. papers. To view these articles, visit, https://doi.org/10.1111/apt.18471 and https://doi.org/10.1111/apt.70157.</p>","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":"61 11","pages":"1843-1844"},"PeriodicalIF":6.6000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.70142","citationCount":"0","resultStr":"{\"title\":\"Letter: Is Enteric Neuropathy Absent in Hypermobility Spectrum Disorders/Hypermobile Ehlers-Danlos Syndrome?\",\"authors\":\"Caitlin Green,&nbsp;Anne Maitland,&nbsp;Steven A. Kautz,&nbsp;Russell Norris,&nbsp;Sunil Patel,&nbsp;Amol Sharma\",\"doi\":\"10.1111/apt.70142\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>We commend Sweerts et al. for their largest-to-date investigation using antroduodenal manometry (ADM) in 50 patients with hypermobility spectrum disorders (HSD) and hypermobile Ehler-Danlos Syndrome (hEDS) compared to 189 non-HSD/hEDS patients [<span>1</span>]. ADM, a labour-intensive and technically challenging procedure, comes the closest to the gold standard of histopathological evaluation of full-thickness tissue specimens for diagnosing enteric myopathy or neuropathy. Key findings of the study were similar rates of antroduodenal dysmotility and delayed gastric emptying, but less enteric dysmotility in HSD/hEDS patients. As discussed, malnutrition was highly prevalent with 76% of HSD/hEDS patients receiving enteral (62%) or parenteral (13%) support. In contrast, the non-HSD/hEDS comparator group had nearly double the proportion of patients not receiving enteral or parenteral nutrition, suggesting differences in meal tolerability. The ADM protocol employed in this study only allowed a ‘one shot’ assessment of enteric function via a single meal. While logistical and technical challenges exist, 24-h recordings present more opportunities to detect enteric motility between meals, in response to multiple meals, in response to a non-meal stimulus through promotility agents, and diurnal variation [<span>2</span>]. The conclusion of a lower prevalence of enteric dysmotility in the HSD/hEDS cohort based on a single meal challenge in patients with poor meal tolerability during ADM may be premature.</p><p>Delayed gastric emptying was present in 85% of the HSD/hEDS cohort. While validated symptom scores for gastroparesis and/or functional dyspepsia were not captured, the corresponding predominant symptom was a cardinal gastroparesis symptom in most patients (nausea/vomiting &gt; 50% and abdominal pain and excessive fullness ~25% of HSD/hEDS group), projected to meet diagnostic criteria for gastroparesis. In gastroparesis overall (i.e., not limited to HSD/hEDS), constipation remains understudied and poorly understood from a pathophysiological standpoint. Fifty-eight percent of patients with gastroparesis have moderate to very severe constipation, and the severity of constipation symptoms correlates with the severity of gastroparesis symptoms [<span>3</span>]. Based on our clinical observations and the lack of use of a prospective stool diary in this study, constipation was probably underreported by HSD/hEDS participants. Underlying rectal evacuation disorders are key drivers of pathophysiology in severe constipation and are present in 60%–75% of patients with HSD/hEDS undergoing anorectal manometry [<span>4, 5</span>].</p><p>While the prevalence of enteric dysmotility or neuropathy in HSD/hEDS remains unclear, more than half of HSD/hEDS patients have associated postural orthostatic tachycardia syndrome and dysautonomia [<span>6</span>]. Transauricular vagal nerve stimulation targeting dysautonomia is promising for functional dyspepsia, also highly prevalent in HSD/hEDS, and improves autonomic function with the ability to monitor and adjust settings remotely [<span>7, 8</span>]. Furthermore, radiologically occult tethered cord syndrome can co-occur with cranio-cervical or cervical instability in patients with hEDS, and surgical management may help in select cases [<span>9</span>]. Neuromodulation of thoracic spinal nerves has shown promise in a proof-of-concept study of patients with diabetic gastroparesis, and is undergoing a sham-controlled randomised clinical trial. It may be beneficial in select cases associated with dysautonomia [<span>10</span>].</p><p>In conclusion, patients with HSD/hEDS suffer from substantial gastrointestinal symptoms and dysfunction. Further studies into understanding the underlying pathophysiology to drive mechanistic treatments are urgently needed.</p><p><b>Caitlin Green:</b> writing – original draft, writing – review and editing. <b>Anne Maitland:</b> writing – review and editing. <b>Steven A. Kautz:</b> writing – review and editing. <b>Russell Norris:</b> writing – review and editing. <b>Sunil Patel:</b> writing – review and editing. <b>Amol Sharma:</b> writing – original draft, writing – review and editing, supervision, conceptualization, visualization, project administration.</p><p>The authors declare no conflicts of interest.</p><p>This article is linked to Sweerts et al. papers. To view these articles, visit, https://doi.org/10.1111/apt.18471 and https://doi.org/10.1111/apt.70157.</p>\",\"PeriodicalId\":121,\"journal\":{\"name\":\"Alimentary Pharmacology & Therapeutics\",\"volume\":\"61 11\",\"pages\":\"1843-1844\"},\"PeriodicalIF\":6.6000,\"publicationDate\":\"2025-05-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.70142\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alimentary Pharmacology & Therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/apt.70142\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/apt.70142","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

我们赞扬sweets等人迄今为止最大规模的调查,他们使用十二指肠测压法(ADM)对50例多动性谱系障碍(HSD)和多动性埃勒-丹洛斯综合征(hEDS)患者与189例非HSD/hEDS患者进行了比较。ADM是一种劳动密集型和技术上具有挑战性的程序,是最接近于诊断肠肌病或神经病变的全层组织标本的组织病理学评估的金标准。该研究的主要发现是HSD/hEDS患者的十二指肠动力障碍和胃排空延迟率相似,但肠道动力障碍发生率较低。如前所述,营养不良非常普遍,76%的HSD/hEDS患者接受肠内(62%)或肠外(13%)支持。相比之下,非hsd /hEDS比较组未接受肠内或肠外营养的患者比例几乎翻了一番,这表明饮食耐受性存在差异。本研究中采用的ADM方案仅允许通过单餐对肠道功能进行“一次性”评估。尽管存在后勤和技术方面的挑战,但24小时记录提供了更多的机会来检测两餐之间的肠道运动,对多餐的反应,通过促进剂对非餐刺激的反应,以及日变化[2]。在ADM期间进餐耐受性差的患者中,基于单餐挑战的HSD/hEDS队列中肠道运动障碍患病率较低的结论可能为时过早。胃排空延迟在85%的HSD/hEDS队列中存在。虽然没有获得胃轻瘫和/或功能性消化不良的有效症状评分,但相应的主要症状是大多数患者的原发性胃轻瘫症状(恶心/呕吐占50%,腹痛和过度饱腹感占HSD/hEDS组的25%),预计符合胃轻瘫的诊断标准。在整个胃轻瘫(即不限于HSD/hEDS)中,便秘的研究仍然不足,从病理生理学的角度来看,便秘的理解也很差。58%的胃轻瘫患者有中度至重度便秘,便秘症状的严重程度与胃轻瘫症状的严重程度[3]相关。根据我们的临床观察和本研究中缺乏前瞻性大便日记的使用,HSD/hEDS参与者可能未充分报告便秘。潜在的直肠排泄障碍是严重便秘病理生理的关键驱动因素,60%-75%的HSD/hEDS患者接受肛肠测压时存在这种障碍[4,5]。虽然HSD/hEDS中肠蠕动障碍或神经病变的患病率尚不清楚,但超过一半的HSD/hEDS患者伴有体位性心动过速综合征和自主神经障碍。针对自主神经异常的经耳迷走神经刺激有望治疗功能性消化不良,这在HSD/hEDS中也非常普遍,并且可以通过远程监测和调节设置来改善自主神经功能[7,8]。此外,放射学上隐匿性脊髓栓系综合征可在hEDS患者中与颅颈或颈椎不稳同时发生,手术治疗可能有助于部分病例的治疗。胸脊神经的神经调节在糖尿病性胃轻瘫患者的概念验证研究中显示出希望,并且正在进行一项假对照随机临床试验。它可能对某些与自主神经异常相关的病例有益。总之,HSD/hEDS患者存在大量的胃肠道症状和功能障碍。迫切需要进一步研究了解潜在的病理生理学,以驱动机械治疗。凯特琳格林:写作-原稿,写作-审查和编辑。安妮·梅特兰:写作-评论和编辑。Steven A. Kautz:写作-评论和编辑。罗素·诺里斯:写作-评论和编辑。苏尼尔·帕特尔:写作——评论和编辑。Amol Sharma:写作-原稿,写作-审查和编辑,监督,概念化,可视化,项目管理。作者声明无利益冲突。这篇文章链接到sweets等人的论文。要查看这些文章,请访问https://doi.org/10.1111/apt.18471和https://doi.org/10.1111/apt.70157。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Letter: Is Enteric Neuropathy Absent in Hypermobility Spectrum Disorders/Hypermobile Ehlers-Danlos Syndrome?

We commend Sweerts et al. for their largest-to-date investigation using antroduodenal manometry (ADM) in 50 patients with hypermobility spectrum disorders (HSD) and hypermobile Ehler-Danlos Syndrome (hEDS) compared to 189 non-HSD/hEDS patients [1]. ADM, a labour-intensive and technically challenging procedure, comes the closest to the gold standard of histopathological evaluation of full-thickness tissue specimens for diagnosing enteric myopathy or neuropathy. Key findings of the study were similar rates of antroduodenal dysmotility and delayed gastric emptying, but less enteric dysmotility in HSD/hEDS patients. As discussed, malnutrition was highly prevalent with 76% of HSD/hEDS patients receiving enteral (62%) or parenteral (13%) support. In contrast, the non-HSD/hEDS comparator group had nearly double the proportion of patients not receiving enteral or parenteral nutrition, suggesting differences in meal tolerability. The ADM protocol employed in this study only allowed a ‘one shot’ assessment of enteric function via a single meal. While logistical and technical challenges exist, 24-h recordings present more opportunities to detect enteric motility between meals, in response to multiple meals, in response to a non-meal stimulus through promotility agents, and diurnal variation [2]. The conclusion of a lower prevalence of enteric dysmotility in the HSD/hEDS cohort based on a single meal challenge in patients with poor meal tolerability during ADM may be premature.

Delayed gastric emptying was present in 85% of the HSD/hEDS cohort. While validated symptom scores for gastroparesis and/or functional dyspepsia were not captured, the corresponding predominant symptom was a cardinal gastroparesis symptom in most patients (nausea/vomiting > 50% and abdominal pain and excessive fullness ~25% of HSD/hEDS group), projected to meet diagnostic criteria for gastroparesis. In gastroparesis overall (i.e., not limited to HSD/hEDS), constipation remains understudied and poorly understood from a pathophysiological standpoint. Fifty-eight percent of patients with gastroparesis have moderate to very severe constipation, and the severity of constipation symptoms correlates with the severity of gastroparesis symptoms [3]. Based on our clinical observations and the lack of use of a prospective stool diary in this study, constipation was probably underreported by HSD/hEDS participants. Underlying rectal evacuation disorders are key drivers of pathophysiology in severe constipation and are present in 60%–75% of patients with HSD/hEDS undergoing anorectal manometry [4, 5].

While the prevalence of enteric dysmotility or neuropathy in HSD/hEDS remains unclear, more than half of HSD/hEDS patients have associated postural orthostatic tachycardia syndrome and dysautonomia [6]. Transauricular vagal nerve stimulation targeting dysautonomia is promising for functional dyspepsia, also highly prevalent in HSD/hEDS, and improves autonomic function with the ability to monitor and adjust settings remotely [7, 8]. Furthermore, radiologically occult tethered cord syndrome can co-occur with cranio-cervical or cervical instability in patients with hEDS, and surgical management may help in select cases [9]. Neuromodulation of thoracic spinal nerves has shown promise in a proof-of-concept study of patients with diabetic gastroparesis, and is undergoing a sham-controlled randomised clinical trial. It may be beneficial in select cases associated with dysautonomia [10].

In conclusion, patients with HSD/hEDS suffer from substantial gastrointestinal symptoms and dysfunction. Further studies into understanding the underlying pathophysiology to drive mechanistic treatments are urgently needed.

Caitlin Green: writing – original draft, writing – review and editing. Anne Maitland: writing – review and editing. Steven A. Kautz: writing – review and editing. Russell Norris: writing – review and editing. Sunil Patel: writing – review and editing. Amol Sharma: writing – original draft, writing – review and editing, supervision, conceptualization, visualization, project administration.

The authors declare no conflicts of interest.

This article is linked to Sweerts et al. papers. To view these articles, visit, https://doi.org/10.1111/apt.18471 and https://doi.org/10.1111/apt.70157.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
15.60
自引率
7.90%
发文量
527
审稿时长
3-6 weeks
期刊介绍: Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信